Skip to main content

Table 1 Clinical characteristics of patients (N = 27)

From: Evaluation of metabolic response with 18F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors

Characteristics

N0

%

Age (yr)

 Mean ± SD* (range)

56 ± 11 (36–82)

 

Gender

 Male

18

67

 Female

9

33

Histopathology (WHOa classification)

 B1

1

4

 B2

7

26

 B3

7

26

 Thymic carcinoma

12

44

Stage at presentation (Masaoka-Koga)

 III

3

11

 IV A

5

19

 IV B

19

70

Platinum-based regimen

 Yes

23

85

 No

4

15

Prior chemotherapy

 Prior therapy for advanced TETsb

6

22

 Prior adjuvant/neoadjuvant therapy

5

19

 No prior therapy

16

59

Prior surgical resection of primary tumor

 Yes

11

41

 No

16

59

Prior radiotherapy

 Yes

5

19

 No

22

81

  1. * SD Standard Deviation
  2. a WHO World Health Organization
  3. b TETs Thymic epithelial tumors